Short answer · Medically reviewed summary · Last updated: 2026-05-08
Hallucinogen Persistent Perception Disorder (HPPD) is a rare condition characterized by the re-experiencing of visual disturbances long after the use of hallucinogenic substances has ceased. These persistent visual phenomena, such as halos or tracers, are not drug-induced at the time of occurrence and can significantly impact a person's daily life and psychological well-being. What are the primary symptoms of Hallucinogen Persistent Perception Disorder? Patients with Hallucinogen Persistent Perception Disorder experience chronic visual distortions that persist for months or years.
2 people with Hallucinogen Persistent Perception Disorder have shared their first-person experience on this question at DiseaseMaps.
What is Hallucinogen Persistent Perception Disorder
What is Hallucinogen Persistent Perception Disorder? Plain-language, medically reviewed definition plus the lived reality told by patients.
Hallucinogen Persistent Perception Disorder (HPPD) is a rare condition characterized by the re-experiencing of visual disturbances long after the use of hallucinogenic substances has ceased. These persistent visual phenomena, such as halos or tracers, are not drug-induced at the time of occurrence and can significantly impact a person's daily life and psychological well-being.
What are the primary symptoms of Hallucinogen Persistent Perception Disorder?
Patients with Hallucinogen Persistent Perception Disorder experience chronic visual distortions that persist for months or years. Unlike a flashback, which is transient, these symptoms are constant or fluctuate in intensity. Common visual manifestations include:
- Visual Snow: Seeing persistent static, similar to an old television screen.
- Tracers: Seeing "trails" behind moving objects.
- After-images: Prolonged visual imprints after looking at an object.
- Halos: Glowing rings or light distortions around light sources.
- Depth/Movement Distortions: Difficulty perceiving size, distance, or stationary objects appearing to move.
How does Hallucinogen Persistent Perception Disorder affect the body?
Hallucinogen Persistent Perception Disorder primarily involves the central nervous system. While the exact pathophysiology remains under investigation, current research suggests it involves a disruption in the brain's sensory filtering mechanisms. It is believed that the thalamus, which acts as a "gatekeeper" for sensory information, may fail to properly filter visual stimuli, leading to the sensory overload characteristic of Hallucinogen Persistent Perception Disorder.
Who is typically affected by this condition?
Data on the exact prevalence of Hallucinogen Persistent Perception Disorder is limited, as many cases remain undiagnosed or unreported. It typically affects individuals who have previously used hallucinogens, though it does not occur in every user, suggesting a potential underlying biological or genetic vulnerability. Within the DiseaseMaps.org community, 260 individuals have connected to share their experiences, highlighting that while rare, those affected often face significant isolation and require specialized support.
What differentiates Hallucinogen Persistent Perception Disorder from other conditions?
It is critical to distinguish Hallucinogen Persistent Perception Disorder from other neurological or psychiatric conditions. Unlike schizophrenia or other psychotic disorders, individuals with HPPD maintain clear reality testing; they understand that the visual distortions are not "real." Furthermore, clinicians must rule out conditions like migraine aura, occipital lobe epilepsy, or structural brain lesions before confirming an HPPD diagnosis.
Next steps
- Consult a neurologist or psychiatrist experienced in neuro-visual disorders.
- Exercise caution with medications; some SSRIs and antipsychotics (e.g., risperidone) have been reported to exacerbate Hallucinogen Persistent Perception Disorder symptoms.
- Join the community of 260+ members at DiseaseMaps.org to share experiences and coping strategies.
- Keep a detailed log of your visual symptoms and any triggers to assist your physician in clinical assessment.
Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician regarding a medical condition.
References
- NIH Genetic and Rare Diseases Information Center (GARD)
- Orphanet: Portal for rare diseases and orphan drugs
- PubMed: Clinical reviews on the neurobiology of hallucinogen-induced visual phenomena
- DiseaseMaps.org: Community insights and patient-reported data
Posted Jun 11, 2018 by dayum_som 4020
An inhibitory cortical interneuron, which expresses 5-HT2a receptors and releases GABA upon activation in the V1 in the visual cortex and/or in the lateral geniculate nucleus in the thalamus. This will explain after images and halos because inhibitory signals are important to suppress neural response to stimuli.
R. Lijens et, al. (2014) Hallucinogen persisting perception disorder and the serotonergic system: A comprehensive review including new MDMA-related clinical cases. European neuropsychopharmacology, pp. 1309-1323.
Posted Feb 17, 2019 by Nicolas 4550
